drugset

drugset / Trial / NCT00672724

Efficacy of Ramelteon in Adults With Chronic Insomnia

NCT00672724 ↗

Phase 3 Terminated 1081 enrolled Takeda

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate subjectively reported treatment effects of ramelteon, once daily (QD), in adults with chronic insomnia.

Timeline

Start: 2005-02
Primary completion: 2005-08
Completion: 2005-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ramelteon	Unknown	8 mg	Oral

Indications